CITADEL ADVISORS LLC

Position in ORKA — Oruka Therapeutics, Inc.

CIK 1423053 MIAMI, FL

Back to ORKA Full portfolio

Position in ORKA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$49,419,689

+$27,411,053 QoQ

Shares Held

1,007,537

+38.8% QoQ

Ownership

1.67%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2025

3 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ORKA Over Time

Shares Held

Position Value (USD)

Derivatives in ORKA

reported options exposure · as of Mar 31, 2026

CallValue

$539,550

CallShares

11,000

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,780,363,972 across 373 Biotechnology names. ORKA ranks #27 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	2,182,571	$356,894,009
2	ONC	BeOne Medicines Ltd.	1,032,298	$306,561,536
3	BMRN	Biomarin Pharmaceutical Inc	4,512,634	$254,918,694
4	JAZZ	Jazz Pharmaceuticals plc	1,259,444	$238,097,887
5	MDGL	Madrigal Pharmaceuticals, Inc.	453,843	$237,573,195
6	BBIO	BridgeBio Pharma, Inc.	3,173,940	$235,696,783
7	TERN	Terns Pharmaceuticals, Inc.	3,218,810	$169,695,662
8	PTGX	Protagonist Therapeutics, Inc	1,551,900	$163,570,260

All Filings in ORKA

Export CSV

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$49,419,689	1,007,537	+9059.4%	Shares	Defined	2026-05-15
2026-03-31	$539,550	11,000	-98.5%	Call	Defined	2026-05-15
2025-12-31	$22,008,636	726,118	+129.1%	Shares	Defined	2026-02-17
2025-09-30	$6,093,717	316,886	+2435.1%	Shares	Defined	2025-11-14
2025-09-30	$240,375	12,500	—	Call	Defined	2025-11-14
No filing history on record for this holder in this stock.